1) MRSA
甲氧西林耐药金黄色葡萄球菌
1.
RESULTS: The result showed that the ED50S of the combination of tienam and netilmycin in the treatment of MRSA 98-15 and 98-17 infections were 16.
目的：评价亚胺培南／西司他丁联合奈替米星对甲氧西林耐药金黄色葡萄球菌感染小鼠模型的体内保护作用。
2) hetero-MRSA
异质性甲氧西林耐药金黄色葡萄球菌
1.
Objective To develop a new method for the isolation of heterogeneous methecillin-resistant staphylococcus aureus(hetero-MRSA)and study its application in clinical practice.
目的初步建立异质性甲氧西林耐药金黄色葡萄球菌(heterogeneous m ethec illin-resistantStaphylococcus aureus,hetero-MRSA)检测方法,并对hetero-MRSA检测的临床意义进行探讨。
3) Methicillin-resistant Staphylococcus aureus(MRSA)
甲氧西林耐药金黄色葡萄球菌（MRSA）
4) Cyclization
2-甲氧基甲氧基
5) Trimethoprim
甲氧苄啶
1.
Determination of Trimethoprim by Synchronous Enhanced Spectrofluorimetry;
甲氧苄啶的同步增敏荧光光谱分析法研究
2.
Spectrophotometric Determination of Trimethoprim Based on Charge-Transfer Reaction with p-Nitrophenol;
对硝基酚荷移分光光度法测定甲氧苄啶的含量
3.
Spectrophotometric Determination of Trimethoprim Based on the Charge Transfer Reaction between Trimethoprim and Purpurin;
甲氧苄啶与茜素红的荷移反应及其测定
6) methoxy
甲氧基
1.
4-Methoxytriphenylamine(MeO-TPA) and 4,4′-dimethoxy-triphenylamine(DMeO-TPA) with good solubility in common organic solvents were synthesized by Ullmann reaction.
通过Ullmann反应合成了4-甲氧基三苯胺(MeO-TPA)和4,4′-二甲氧基三苯胺(DMeO-TPA)两种具有良好溶解性的甲氧基取代三苯胺,通过FTIR、1H NMR和元素分析等手段对其进行了表征,并采用循环伏安(CV)结合UV-Vis吸收光谱测试了其能级结构。
2.
The extractable quantity is related to the time ofhydrolysis and thd ester-value of the linseed gum and the content of methoxy is relatedto the temperature of the extracting.
该胶可用水、碱、酸提取，提取量与水解温度和时间有关，胶的酯化度和甲氧基含量与提取温度有关。
参考词条
补充资料：耐甲氧西林金黄色葡萄球菌
耐甲氧西林金黄色葡萄球菌
属MRSA是引起医院感染的重要病源之一，除对甲氧西林耐药外，还对临床上广泛应用的多种抗生素耐药，所致感染呈散发或爆发流行，治疗困难，病死率高，是临床治疗上的一大难题。由MRSA引起的感染已遍及全世界。国内MRSA感染有增高趋势，占金黄色葡萄球菌的5%～47%。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。